annual CFO:
-$391.24M-$24.48M(-6.67%)Summary
- As of today (June 29, 2025), IBRX annual cash flow from operations is -$391.24 million, with the most recent change of -$24.48 million (-6.67%) on December 31, 2024.
- During the last 3 years, IBRX annual CFO has fallen by -$116.82 million (-42.57%).
- IBRX annual CFO is now -157.21% below its all-time high of -$152.11 million, reached on December 31, 2019.
Performance
IBRX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$85.91M-$761.00K(-0.89%)Summary
- As of today (June 29, 2025), IBRX quarterly cash flow from operations is -$85.91 million, with the most recent change of -$761.00 thousand (-0.89%) on March 31, 2025.
- Over the past year, IBRX quarterly CFO has increased by +$21.08 million (+19.70%).
- IBRX quarterly CFO is now -176.16% below its all-time high of -$31.11 million, reached on March 31, 2020.
Performance
IBRX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$370.16M+$21.08M(+5.39%)Summary
- As of today (June 29, 2025), IBRX TTM cash flow from operations is -$370.16 million, with the most recent change of +$21.08 million (+5.39%) on March 31, 2025.
- Over the past year, IBRX TTM CFO has increased by +$19.27 million (+4.95%).
- IBRX TTM CFO is now -1089.95% below its all-time high of -$31.11 million, reached on March 31, 2020.
Performance
IBRX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IBRX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.7% | +19.7% | +5.0% |
| 3 y3 years | -42.6% | -14.7% | -28.1% |
| 5 y5 years | -157.2% | -176.2% | -1090.0% |
IBRX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.6% | at low | -14.7% | +25.5% | -28.1% | +12.2% |
| 5 y | 5-year | -157.2% | at low | -176.2% | +25.5% | -1090.0% | +12.2% |
| alltime | all time | -157.2% | at low | -176.2% | +25.5% | -1090.0% | +12.2% |
IBRX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$85.91M(+0.9%) | -$370.16M(-5.4%) |
| Dec 2024 | -$391.24M(+6.7%) | -$85.14M(-13.8%) | -$391.24M(-7.1%) |
| Sep 2024 | - | -$98.76M(-1.6%) | -$421.36M(+2.8%) |
| Jun 2024 | - | -$100.35M(-6.2%) | -$410.00M(+5.3%) |
| Mar 2024 | - | -$106.98M(-7.2%) | -$389.43M(+6.2%) |
| Dec 2023 | -$366.76M(+8.7%) | -$115.27M(+31.9%) | -$366.76M(+7.2%) |
| Sep 2023 | - | -$87.40M(+9.6%) | -$342.21M(+2.0%) |
| Jun 2023 | - | -$79.77M(-5.4%) | -$335.41M(-3.3%) |
| Mar 2023 | - | -$84.31M(-7.1%) | -$346.89M(+2.8%) |
| Dec 2022 | -$337.51M | -$90.73M(+12.6%) | -$337.51M(+6.0%) |
| Sep 2022 | - | -$80.60M(-11.7%) | -$318.42M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$91.25M(+21.8%) | -$310.54M(+7.5%) |
| Mar 2022 | - | -$74.93M(+4.6%) | -$288.88M(+5.3%) |
| Dec 2021 | -$274.42M(+59.8%) | -$71.64M(-1.5%) | -$274.42M(+5.4%) |
| Sep 2021 | - | -$72.72M(+4.5%) | -$260.38M(+15.9%) |
| Jun 2021 | - | -$69.59M(+15.1%) | -$224.66M(+11.7%) |
| Mar 2021 | - | -$60.47M(+5.0%) | -$201.09M(+17.1%) |
| Dec 2020 | -$171.72M(+12.9%) | -$57.60M(+55.7%) | -$171.72M(+50.5%) |
| Sep 2020 | - | -$36.99M(-19.6%) | -$114.12M(+48.0%) |
| Jun 2020 | - | -$46.02M(+47.9%) | -$77.13M(+147.9%) |
| Mar 2020 | - | -$31.11M | -$31.11M |
| Dec 2019 | -$152.11M | - | - |
FAQ
- What is ImmunityBio annual cash flow from operations?
- What is the all time high annual CFO for ImmunityBio?
- What is ImmunityBio annual CFO year-on-year change?
- What is ImmunityBio quarterly cash flow from operations?
- What is the all time high quarterly CFO for ImmunityBio?
- What is ImmunityBio quarterly CFO year-on-year change?
- What is ImmunityBio TTM cash flow from operations?
- What is the all time high TTM CFO for ImmunityBio?
- What is ImmunityBio TTM CFO year-on-year change?
What is ImmunityBio annual cash flow from operations?
The current annual CFO of IBRX is -$391.24M
What is the all time high annual CFO for ImmunityBio?
ImmunityBio all-time high annual cash flow from operations is -$152.11M
What is ImmunityBio annual CFO year-on-year change?
Over the past year, IBRX annual cash flow from operations has changed by -$24.48M (-6.67%)
What is ImmunityBio quarterly cash flow from operations?
The current quarterly CFO of IBRX is -$85.91M
What is the all time high quarterly CFO for ImmunityBio?
ImmunityBio all-time high quarterly cash flow from operations is -$31.11M
What is ImmunityBio quarterly CFO year-on-year change?
Over the past year, IBRX quarterly cash flow from operations has changed by +$21.08M (+19.70%)
What is ImmunityBio TTM cash flow from operations?
The current TTM CFO of IBRX is -$370.16M
What is the all time high TTM CFO for ImmunityBio?
ImmunityBio all-time high TTM cash flow from operations is -$31.11M
What is ImmunityBio TTM CFO year-on-year change?
Over the past year, IBRX TTM cash flow from operations has changed by +$19.27M (+4.95%)